Sam Whiting was appointed Chief Medical Officer at Vividion Therapeutics, a wholly owned subsidiary of Bayer.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sam Whiting was appointed Chief Medical Officer at Vividion Therapeutics, a wholly owned subsidiary of Bayer.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vividion Therapeutics (United States)
company in San Diego, United States
Nothing else this week.
-
Bayer
German multinational pharmaceutical, chemical, and agricultural biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireVividion Therapeutics Appoints Sam Whiting, M.D., Ph.D., as Chief Medical Officer Dr. Whiting brings extensive experience in medical oncology spanning patient care, early drug discovery, and late-sta